Anthony G. Quinn
2020
In 2020, Anthony G. Quinn earned a total compensation of $2.9M as Chief Executive Officer at Aeglea BioTherapeutics, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $256,000 |
|---|---|
| Salary | $538,000 |
| Stock Awards | $2,089,861 |
| Other | $25,745 |
| Total | $2,909,606 |
Quinn received $2.1M in stock awards, accounting for 72% of the total pay in 2020.
Quinn also received $256K in non-equity incentive plan, $538K in salary and $25.7K in other compensation.
Rankings
In 2020, Anthony G. Quinn's compensation ranked 3,980th out of 13,090 executives tracked by ExecPay. In other words, Quinn earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,980 out of 13,090 | 70th |
Division Manufacturing | 1,596 out of 5,620 | 72nd |
Major group Chemicals And Allied Products | 605 out of 2,253 | 73rd |
Industry group Drugs | 523 out of 1,953 | 73rd |
Industry Pharmaceutical Preparations | 397 out of 1,458 | 73rd |
Source: SEC filing on April 21, 2022.
Quinn's colleagues
We found one more compensation record of an executive who worked with Anthony G. Quinn at Aeglea BioTherapeutics in 2020.
2020
Leslie Sloan
Aeglea BioTherapeutics
Chief Operating Officer
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019